Most Clicked StoriesMore >


Pfizer makes offer to buy Sobi, sources say

BIO SmartBrief | May 01, 2015

Pfizer reportedly is negotiating to purchase Sobi, which has a market value of $4.3 billion. Pfizer created a research unit for rare diseases, which Sobi specializes in, and sells a hemophilia drug produced by Sobi. Reuters (04/30)


Fujifilm finalizes $307M acquisition of Cellular Dynamics

BIO SmartBrief | May 05, 2015

FDA finalizes 3 biosimilars guidance documents

BIO SmartBrief | Apr 30, 2015

Celgene partners with Agios Pharmaceuticals on cancer candidate

BIO SmartBrief | Apr 30, 2015

Merck partners with PeptiDream on peptide development

BIO SmartBrief | May 04, 2015

Loss of patent protections will drive sales of biosimilars

BIO SmartBrief | Apr 30, 2015

Monsanto again offers to buy Syngenta, sources say

BIO SmartBrief | May 01, 2015

Amgen's melanoma immunotherapy wins backing from advisory panel to FDA

BIO SmartBrief | Apr 30, 2015

More drugmakers start talks with insurers before product launch

BIO SmartBrief | May 05, 2015

IPO brings in nearly $147M for Blueprint Medicines

BIO SmartBrief | Apr 30, 2015


Find BIO SmartBrief Issues by Date:



BIO News More >


Faster & better connections with quality R&D vendors

BIO SmartBrief | May 06, 2015

Industrial biotechnology with a French twist!

BIO SmartBrief | May 06, 2015

BIO International Convention -- Register Now

BIO SmartBrief | May 05, 2015

Are you looking for top biotech talent? Or looking for a biotech job?

BIO SmartBrief | May 05, 2015

FDA/Sponsor Interactions During Drug Development: Preliminary Data

BIO SmartBrief | May 04, 2015




Sign up for BIO SmartBrief



Designed specifically for biotechnology industry professionals like you, BIO SmartBrief is a FREE daily e-mail newsletter. It provides the latest news and information you need to stay informed about important biotech issues. Learn more